Cargando…
Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives
Inflammatory bowel disease (IBD) is a chronic relapsing/remitting inflammatory illness of the gastrointestinal tract of unknown aetiology. Despite recent advances in decoding the pathophysiology of IBD, many questions regarding disease pathogenesis remain. Genome-wide association studies (GWAS) and...
Autores principales: | Assadsangabi, Arash, Evans, Caroline A., Corfe, Bernard M., Lobo, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350533/ https://www.ncbi.nlm.nih.gov/pubmed/30774653 http://dx.doi.org/10.1155/2019/1426954 |
Ejemplares similares
-
Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-associated cancer
por: Corfe, Bernard M, et al.
Publicado: (2015) -
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases
por: Park, Sang Hyoung, et al.
Publicado: (2020) -
Proteomic research in sarcomas – current status and future opportunities
por: Burns, Jessica, et al.
Publicado: (2020) -
Proteomics in Biomarker Discovery for Tuberculosis: Current Status and Future Perspectives
por: Guo, Jiubiao, et al.
Publicado: (2022) -
Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)